Release Date: 13/07/12 11:43 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 499.15KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%